# Product Context: HealthCore Forecasting Model Trust Verification

## 1. The Core Business Challenge
HealthCore operates a $28M outpatient healthcare services network across 12 clinics in the United States and the United Kingdom. Under the leadership of CEO **Dr. Sandra Okonkwo**, the company is transitioning from unintegrated legacy tracking systems toward a centralized data layer managed by **HealthCore Digital**. 

Moving an unvalidated forecasting engine to staging or production presents an immediate threat to corporate operational cash flows. Incurring massive errors in revenue or patient volume projections could lead to localized staffing deficits across the 120 clinical staff members or cross-border cash shortfalls between the US and UK operating units. 

The purpose of this technical evaluation is to answer the Tech Lead's ticket with unambiguous, empirical evidence:
1. **Does the model show underfitting, overfitting, or is it reasonably well fitted?**
2. **How stable is its performance when you change which portion of the data you train on?**
3. **If there is a problem, what is the specific corrective action that should be taken?**

Subjective claims such as "the model works fine" will not be accepted by Dr. Okonkwo, who is deeply skeptical of unproven technology tools.

## 2. Evaluation Metrics & Business Justification
Evaluating model quality requires a direct mapping between mathematical metrics and actual corporate operational expenses. The pipeline calculates both **MAE** and **RMSE** to explicitly isolate distinct types of financial and operational impacts across HealthCore's billing architecture:

┌───────────────────────────────────────────────────────────┐
│ HEALTHCORE REGRESSION METRIC MATRIX │
├─────────────────────────────┬─────────────────────────────┤
│ Mean Absolute Error (MAE) │ Root Mean Squared Error │
│ │ (RMSE) │
├─────────────────────────────┼─────────────────────────────┤
│ Measures predictable, │ Penalizes larger, volatile │
│ average baseline error per │ outlier misses heavily via │
│ sales and billing cycle. │ a squaring penalty. │
├─────────────────────────────┴─────────────────────────────┤
│ Core Justification: While MAE captures the steady, linear │
│ miscalculations in standard private pay or small NHS │
│ contracts, RMSE is highly sensitive to large outlier │
│ errors. For Tom Callahan's billing team, a │
│ sudden, unpredicted spike in claims denials (currently at │
│ a damaging 14% in the US) or a sudden revenue variance │
│ can destabilize clinic operations. │
└───────────────────────────────────────────────────────────┘

## 3. Structural Evaluation Framework
The core technical report will evaluate and interpret structural signals using the following criteria to drive specific corrective adjustments:

*   **Underfitting Signal:** Both training and validation error curves converge tightly but remain at a high, unacceptable error ceiling.
    *   *HealthCore Impact:* The model fails to capture baseline sales patterns, seasonal signals, or billing dynamics across EHR platforms.
    *   *Action:* Enhance model capacity or refine feature engineering quality (e.g., optimizing lag variables for US insurance submission cycles). Do not attempt to fix by adding more training data.
*   **Overfitting Signal:** A persistent, significant gap remains where training error is low but validation error is high.
    *   *HealthCore Impact:* The model has memorized historical noise or specific clinic anomalies, which will cause it to fail unpredictably when deployed across different geographical regions (e.g., misapplying Texas trends to London clinics).
    *   *Action:* Introduce structural regularization, reduce parameter footprint, or expand historical training depth.
*   **Reasonably Well Fitted Signal:** Training and validation lines converge smoothly to a low, stable error rate, matching the cross-validation stability target ($\text{Mean} \pm \text{SD}$).
    *   *HealthCore Impact:* Low risk. Provides the objective, empirical justification required to clear the model for promotion to staging.
